In a new study, Charlie Gersbach describes how he successfully harnessed Class 1 CRISPR systems to turn target genes on and off and edit the epigenome in human cells for the first time.

Lingchong You developed a new technology to create biologic drugs using specially engineered bacteria that burst and release useful proteins when they sense that their capsule is becoming too crowded.

Xiling Shen principal investigator in new DARPA project.

Here are summaries of a selection of the papers published by GCB faculty in August 2019:

Banned painkiller had a unique effect on the model fish, so they shifted focus to figure out why

Here are summaries of a selection of the papers published by GCB faculty in July 2019:

Early studies suggest restricting an amino acid works similarly to chemotherapy, radiation. The hope that food might somehow serve as a weapon in the cancer fight has...

Eight underclassmen from universities across North Carolina spent their summer at Duke and North Carolina Central University (NCCU) getting their first dose of real lab experience. They presented their research findings in a poster presentation on July 26

Xiling Shen, Ph.D., received a grant for his new project, Human Cell Atlas Along the Gut-Brain Axis, from the Chan Zuckerberg Initiative (CZI) to become a part of CZI's Seed Networks for the Human Cell Atlas.

The Beckman Foundation highlighted Lawrence David and his lab in a video.